Open AccessThe role of MT1-MMP in the progression and metastasis of osteosarcoma
Author(s) -
Hannah L. M. Spencer,
Steven D. Shnyder,
Paul M. Loadman,
Robert A. Falconer
Publication year - 2022
Publication title -
journal of cancer metastasis and treatment
Language(s) - English
Resource type - Journals
eISSN - 2454-2857
pISSN - 2394-4722
DOI - 10.20517/2394-4722.2021.174
Subject(s) - matrix metalloproteinase , osteosarcoma , metastasis , angiogenesis , cancer research , tumor progression , cancer , medicine , bioinformatics , biology
The dysregulation of Membrane - type 1 matrix metalloproteinase (MT1-MMP) has been extensively studied in numerous cancer types, and plays key roles in angiogenesis, cancer progression, and metastasis. MT1-MMP is a predictor of poor prognosis in osteosarcoma (OS), yet the molecular mechanisms of disease progression are unclear. This review provides a summary of the literature relating to the gene and protein expression of MT1-MMP (MMP-14) in OS clinical samples, evaluates the expression in cell lines and experimental models, and analyses its potential role in the progression and metastasis of OS. In addition, the therapeutic potential of MT1-MMP as a drug target has been assessed. Due to the biological complexity of MMPs, inhibition has proven to be challenging. However, exploiting the expression and proteolytic capacity of MT1-MMP could open new avenues in the search for novel, safer and selective drugs for use in OS.